JNJ dividend yield: 3.36%. CVX dividend yield: 4.28%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. Chevron is a Dividend Aristocrat with 37+ consecutive years of increases. Strong balance sheet and low breakeven oil price allow dividend growth even in downturns. The Hess acquisition adds world-class assets in Guyana. Chevron's integrated model provides stability across commodity cycles.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Chevron is a Dividend Aristocrat with 37+ consecutive years of increases. Strong balance sheet and low breakeven oil price allow dividend growth even in downturns. The Hess acquisition adds world-class assets in Guyana. Chevron's integrated model provides stability across commodity cycles.
JNJ currently offers a 3.36% yield (4.96/share/year) while CVX offers 4.28% (6.52/share/year). CVX provides higher current income. However, CVX has grown its dividend faster (6.1% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs CVX earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. CVX pays approximately $428/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $1,066/year (CVX).
Does JNJ or CVX pay monthly dividends?
JNJ pays quarterly dividends. CVX pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs CVX comparison by email
Save your analysis + get weekly dividend insights. Free forever.